Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real Practice

Completed

• Conditions: Asthma

• Registration Number: NCT01438255
• Lead Sponsor: Handok Inc.

Brief Summary

This is a prospective, non-comparative, open, observational study.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07
• Study First Submitted: 2011-09-08
• Study First Submitted QC: 2011-09-20
• Study First Posted: 2011-09-22
• Primary Completion: 2012-07
• Status Verified: 2012-08
• Last Update Submitted: 2012-08-21
• Last Update Posted: 2012-08-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 274

Inclusion Criteria

• Children who is prescribed with ciclesonide for asthma

Exclusion Criteria

• Subjects with contraindications to ciclesonide use
• Subjects with clinically relevant concomitant disease that could compromise the patient's safety should not be included in this study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Asthma control day	12weeks

Secondary Outcome Measures

Name	Time	Method
Morning peak expiratory flow	12weeks
asthma exacerbation	12weeks
The number of Reliever use	12weeks
Asthma symptom score	12weeks
Number of Participants with Adverse Events	12weeks

Trial Locations

Locations (1)

Handok Pharmaceuticals; 🇰🇷 Seoul, Korea, Republic of